# Therapeutics Architect at NOETIK

- Company: NOETIK
- What the company does: Noetik is an AI-native biotechnology company that applies self-supervised machine learning to large-scale human multimodal spatial omics datasets with the aim of developing precision cancer therapies. Backed by DCVC (Data Collective).
- Company website: https://noetik.ai
- Type: Startups
- Level: Mid level
- Location: San Francisco or New York
- Work setup: On-site
- Posted: 2026-09-08
- Apply by: 2026-10-23
- Apply: https://job-boards.greenhouse.io/noetik/jobs/4394961009
- Page: https://www.1752.vc/careers/jobs/noetik-therapeutics-architect/

## About the role

You'll join a cross-functional therapeutics team responsible for surfacing promising therapeutic opportunities, pressure-testing their scientific and translational logic, and shaping how programs move through the pipeline. We're intentionally building a different kind of therapeutics group to support this work, because turning human foundation models / insights into new therapeutic concepts and real patient impact requires a fundamentally different way of working.

## What they're looking for

- PhD, MD, or equivalent experience in cancer biology, immunology, pharmacology, molecular biology, translational medicine, or a related discipline
- Bona fide experience on drug discovery or development programs, with a working feel for the scientific, operational, and strategic go/no-go decisions required to move a program forward… or kill it
- Strong intuition for turning hypotheses into viable therapeutic programs, spanning target validation and modality considerations through translational strategy and positioning
- Genuine comfort in a room that mixes biology, machine learning, computational science, and strategy, where no one person holds the singular answer
- Hands-on use of modern AI tools in scientific work, with examples of how they’ve changed the way you investigate questions, evaluate evidence, or make therapeutic decisions
- A systems-thinking mindset with the ability to prioritize across competing scientific opportunities

Tags: Therapeutics